US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Beauty, Skincare & Aesthetics ETF

27.75

-0.3509-1.25%

Volume:36

Turnover:1K

Market Cap:971.12K

PE:- -

High:27.75

Open:28.10

Low:27.75

Close:28.10

52wk High:29.89

52wk Low:24.32

Shares:35.00K

Float Shares:35.00K

Volume Ratio:0.00

T/O Rate:0.10%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Estée Lauder Names Justin Boxford Global President of Luxury Beauty Brands

The EstÉE Lauder Companies Announces Brand Leadership Appointments

THOMSON REUTERS

AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints

MT Newswires Live

AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study

AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS

AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals

Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26

THOMSON REUTERS

Abbvie - Etentamig Demonstrates Low Rates of Cytokine Release Syndrome and Fatal Infections

THOMSON REUTERS

Abbvie - Etentamig Achieves 74% Orr and 60% Risk Reduction in Phase 3 Cervino Trial

THOMSON REUTERS

Abbvie Announces Positive Topline Results from the Phase 3 Cervino Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma

THOMSON REUTERS

AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics

MT Newswires Live

Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger

Abbvie Completes Acquisition of Apogee Therapeutics

THOMSON REUTERS

Abbvie - Reaffirms 2026 Q3 Adj Diluted EPS Guidance $3.84-$3.88

THOMSON REUTERS

AbbVie to Present at Morgan Stanley Global Healthcare Conference Fireside Chat

Estee Lauder’s Sandra Main to Retire as Global Brand President of La Mer, Skin Care Brands by End-2026

Align Technology Inc. Stock Outperforms Competitors on Strong Trading Day

STAAR Surgical Appoints Ben Park as Chief Technology Officer

MT Newswires Live

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Allergan Aesthetics Unveils Layered Beauty Report on Global Shift Toward Personalized Aesthetic Care

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/GLAM/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":27.7464,"timestamp":1789070400000,"preClose":28.0973,"halted":0,"volume":36,"delay":0,"changeRate":-0.012488744470109203,"floatShares":35000,"shares":35000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.3509,"latestTime":"09-11 04:44:49 EDT","open":28.0973,"high":27.7464,"low":27.7464,"amount":1010,"amplitude":0,"askPrice":44.11,"askSize":100,"bidPrice":11.16,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"exchange":"CBOE","adjPreClose":27.7464,"nav":28.11,"aum":983850,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.0973,"preClose":27.7464,"latestTime":"16:10 EDT","volume":6,"amount":166.4784,"timestamp":1789071007579,"change":0.3509,"changeRate":0.012647,"amplitude":0},"volumeRatio":0.0035086351340910004,"impliedVol":0.5022,"impliedVolPercentile":0.6709},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":35000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.0035086351340910004,"shares":35000,"dividePrice":0,"high":27.7464,"amplitude":0,"preClose":28.0973,"low":27.7464,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":27.7464,"eps":0,"divideRate":0,"volume":36,"delay":0,"ttmEps":0,"open":28.0973,"prevYearClose":25.82,"prevWeekClose":29.069,"prevMonthClose":28.9677,"prevQuarterClose":27.6454,"fiveDayClose":29.0341,"twentyDayClose":28.2971,"sixtyDayClose":26.2792},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664687000","title":"Estée Lauder Names Justin Boxford Global President of Luxury Beauty Brands","url":"https://stock-news.laohu8.com/highlight/detail?id=2664687000","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664687000?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:37","pubTimestamp":1788446260,"startTime":"0","endTime":"0","summary":"Estée Lauder names Justin Boxford global president of luxury beauty brandsEstée Lauder created a Global President, Luxury Beauty Brands role, naming Justin Boxford to oversee La Mer alongside other lu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL2PfpdR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2404859741.USD","BK4548","LU1064131342.USD","LU2404859667.USD","LU2264538146.SGD","BK4558","LU0690374961.EUR","BK4504","LU2552382215.SGD","BK4533","LU2552382058.USD","BK4585","BK4183","GLAM","LU0690374615.EUR","EL","BK4588","LU1988902786.USD","LU2552382132.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870020","title":"The EstÉE Lauder Companies Announces Brand Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870020","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870020?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:37","pubTimestamp":1788446220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA8VM31T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0690374615.EUR","LU1064131342.USD","LU2264538146.SGD","BK4533","LU1988902786.USD","LU2404859741.USD","LU2552382215.SGD","GLAM","BK4548","BK4585","LU2552382058.USD","LU0690374961.EUR","LU2404859667.USD","BK4558","BK4588","LU2552382132.HKD","BK4183","EL","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664870565","title":"AbbVie's Phase 3 Study of Etentamig in Multiple Myeloma Meets Dual Primary Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2664870565","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664870565?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:07","pubTimestamp":1788444473,"startTime":"0","endTime":"0","summary":"AbbVie's (ABBV) phase 3 study of etentamig in patients with triple-class exposed relapsed/refractory multiple myeloma met its dual primary endpoints of objective response rate and progression-free sur","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089984988.USD","LU0820561909.HKD","IE0004445239.USD","PPH","IE00BJT1NW94.SGD","RXL","SG9999015952.SGD","FHLC","LU1057294990.SGD","LU0661504455.SGD","TRUH","LU2468319806.SGD","LU1923622614.USD","LU2237443549.SGD","IE00BVYPNW00.USD","LU0320765646.SGD","FTXH","GLAM","LU0289739699.SGD","LU1670628061.USD","IE000SO60NU8.SGD","SG9999001440.SGD","PJP","MEDX","SG9999003800.SGD","LU2357627491.SGD","VHT","LU0965509010.AUD","AGNG","IYH","LU0256863902.USD","LU0456855351.SGD","LU1718418525.SGD","LU0965509283.SGD","IXJ","BK4581","LU0289739343.SGD","ABBV","LU1267930490.SGD","LU1732799900.SGD","IE00BGHQF631.EUR","IE00BBT3K403.USD","JDOC","XLV","LU2129689514.USD","IE0009355771.USD","SG9999015986.USD","LU2237443465.HKD","LU2433249047.HKD","IE000WAW04H5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587722","title":"AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587722","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587722?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:42","pubTimestamp":1788442920,"startTime":"0","endTime":"0","summary":"AbbVie said a drug to treat blood cancer met its dual primary endpoints in a phase 3 study.The company said etentamig demonstrated a significantly higher objective response rate and improvements in pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"AbbVie Says Blood Cancer Drug Met Dual Primary Endpoints in Phase 3 Study","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDGV0183.EUR","BK4585","LU1093756325.SGD","LU2089283258.USD","LU1291159041.SGD","IE0000B7K699.USD","IE00B42XCP33.USD","LU0124676726.USD","LU1989771016.USD","LU2237443978.SGD","TRUH","LU0203347892.USD","LU2129689431.USD","GLAM","MEDX","IE00BLSP4452.SGD","LU0256863902.USD","LU0861579265.USD","LU0098860793.USD","LU0472753341.HKD","LU1244550221.USD","FHLC","IXJ","LU1551013342.USD","RXL","IE00B19Z3B42.SGD","LU0859254822.USD","IE00BBT3K403.USD","XLV","PPH","LU0211328371.USD","LU0868494617.USD","LU0868494708.USD","IE000F7OJYX1.SGD","FTXH","LU0823416689.USD","JDOC","IYH","AGNG","ABBV","SG9999001440.SGD","PJP","LU0289961442.SGD","LU1003077747.HKD","IE00BVYPNV92.GBP","LU0170899867.USD","VHT","IE000BZT7R73.USD","LU2112291526.USD","LU1732799900.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664587723","title":"AbbVie announces Phase 3 Cervino study met dual primary endpoints of ORR, PFS","url":"https://stock-news.laohu8.com/highlight/detail?id=2664587723","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664587723?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:25","pubTimestamp":1788441947,"startTime":"0","endTime":"0","summary":"AbbVie (ABBV) announced positive topline results from the Phase 3 Cervino study evaluating etentamig, an investigational BCMA x CD3 bispecific T-ce...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbvie-announces-phase-3-cervino-study-met-dual-primary-endpoints-of-orr-pfs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbvie-announces-phase-3-cervino-study-met-dual-primary-endpoints-of-orr-pfs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0203347892.USD","LU1093756325.SGD","LU0320765646.SGD","ABBV","LU0942090050.USD","LU2357627491.SGD","IE00BLSP4239.USD","FHLC","IE000WAW04H5.SGD","BK4550","SG9999011175.SGD","IYH","LU0417517546.SGD","TRUH","LU0912757837.SGD","LU0472753341.HKD","LU0795875169.SGD","GLAM","LU0868494617.USD","LU0057025933.USD","IXJ","MEDX","AGNG","LU1057294990.SGD","LU2089284900.SGD","BK4585","PPH","LU1929549753.HKD","LU1585245621.USD","LU2237443465.HKD","ORR","LU1244550494.USD","LU2129689431.USD","VHT","LU0124676726.USD","LU0882574055.USD","LU0256863811.USD","PJP","JDOC","IE000F7OJYX1.SGD","LU0820561909.HKD","XLV","BK4559","FTXH","LU1496350171.SGD","IE0004445239.USD","LU0965509283.SGD","RXL","LU1989772840.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664877895","title":"AbbVie's Blood Cancer Drug Meets Late-Stage Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664877895","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664877895?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:18","pubTimestamp":1788441527,"startTime":"0","endTime":"0","summary":"AbbVie's blood cancer drug meets late-stage trial goalsSept 3 (Reuters)-AbbVieABBV.Nsaid on Thursday its drug for a type of blood cancer has met the main goals of a late-stage trial.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","LU0203345920.USD","LU0114720955.EUR","LU0726765562.USD","RXL","ABBV","LU2112291526.USD","LU0820561909.HKD","BK4585","IE000MB6IJN5.SGD","LU0472753341.HKD","PPH","LU1496350171.SGD","IE00BVYPNW00.USD","XLV","IE00BLSP4239.USD","LU0256863902.USD","LU2089283258.USD","LU1585245621.USD","IYH","AGNG","IXJ","LU1934455277.USD","MEDX","PJP","LU1989772923.USD","LU0985320562.USD","SG9999001440.SGD","TRUH","SG9999015945.SGD","JDOC","FTXH","IE00BBT3K403.USD","LU0128525929.USD","LU1934455863.HKD","IE00BN8TJ469.HKD","SG9999015952.SGD","LU0289961442.SGD","LU0942090050.USD","IE0009355771.USD","LU0057025933.USD","LU0211328371.USD","LU0098860793.USD","IE00B3PB1722.GBP","VHT","FHLC","LU0395794307.EUR","IE0004445239.USD","LU2357627491.SGD","LU0820561818.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887207","title":"Abbvie - Phase 3 Cervino Study Met Dual Primary Endpoints; Full Results to be Presented Sept 23-26","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887207?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4533","LU1718418525.SGD","LU0122379950.USD","LU0234572021.USD","LU2087621335.USD","LU0859254822.USD","IE00BBT3K403.USD","FTXH","LU1244550577.SGD","TRUH","IYH","LU2237443549.SGD","LU1291159041.SGD","LU1496350171.SGD","LU0114720955.EUR","PJP","LU2089984988.USD","LU2347655073.USD","LU1244550221.USD","LU1585245621.USD","LU2125909593.SGD","LU1670628061.USD","MEDX","LU1236620834.HKD","LU0965509010.AUD","AGNG","IXJ","LU1983299246.USD","PPH","LU1057294990.SGD","LU2133065610.SGD","LU1093756325.SGD","LU1551013425.SGD","LU1839511570.USD","IE00B4R5TH58.HKD","LU0553294199.USD","LU0511384066.AUD","JDOC","LU0098860793.USD","ABBV","GLAM","FHLC","LU1023059063.AUD","LU0689472784.USD","LU0820561909.HKD","VHT","XLV","RXL","IE00BN8TJ469.HKD","LU1267930573.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872073","title":"Abbvie - Etentamig Demonstrates Low Rates of Cytokine Release Syndrome and Fatal Infections","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872073?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PJP","LU2237443465.HKD","LU0795875169.SGD","LU2089283258.USD","FTXH","IYH","LU1732800096.USD","LU1839511570.USD","LU1934455194.USD","ABBV","SG9999011175.SGD","XLV","LU0234572021.USD","LU2237443382.USD","LU0545039389.USD","SG9999003800.SGD","IXJ","LU1244550494.USD","IE00BBT3K403.USD","BK4588","TRUH","LU0128525929.USD","LU0456855351.SGD","LU1989771016.USD","LU0859254822.USD","LU1244550577.SGD","SG9999001440.SGD","IE00B19Z3B42.SGD","GLAM","LU1430594728.SGD","LU1093756325.SGD","LU2125909593.SGD","PPH","LU0170899867.USD","IE00B3PB1722.GBP","LU1934455863.HKD","MEDX","FHLC","SG9999015945.SGD","IE00B2B36J28.USD","VHT","LU0861579265.USD","LU0943347566.SGD","JDOC","LU0289961442.SGD","RXL","LU0511384066.AUD","LU0942090050.USD","IE000WAW04H5.SGD","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664720768","title":"Abbvie - Etentamig Achieves 74% Orr and 60% Risk Reduction in Phase 3 Cervino Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664720768","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664720768?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739343.SGD","TRUH","LU2133065610.SGD","PPH","LU0545039389.USD","LU0417517546.SGD","RXL","FHLC","FTXH","LU1934455194.USD","LU0726765562.USD","LU1093756325.SGD","LU0868494708.USD","LU0432979614.USD","LU0965508806.USD","ABBV","LU0170899867.USD","LU2237443382.USD","GLAM","LU1983299246.USD","LU0882574055.USD","IXJ","JDOC","SG9999011175.SGD","BK4588","LU1670628061.USD","VHT","AGNG","LU0861579265.USD","IE000MB6IJN5.SGD","LU1244550577.SGD","LU1934455277.USD","LU0689472784.USD","LU1236620834.HKD","LU1929549753.HKD","XLV","PJP","IE00BJJMRZ35.SGD","LU0859254822.USD","MEDX","BK4533","IE000SO60NU8.SGD","LU1003077747.HKD","LU0795875169.SGD","BK4139","LU0965509283.SGD","IYH","IE000BZT7R73.USD","IE00BJT1NW94.SGD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487207","title":"Abbvie Announces Positive Topline Results from the Phase 3 Cervino Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487207?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:15","pubTimestamp":1788441300,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9C2QXL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0965508806.USD","LU0820561818.USD","LU1244550577.SGD","LU0310800379.SGD","LU2357627491.SGD","LU0417517546.SGD","PPH","IE000F7OJYX1.SGD","LU0432979614.USD","LU0128525929.USD","IE000BZT7R73.USD","LU1923622614.USD","LU0203347892.USD","LU0289961442.SGD","LU1670627923.USD","TRUH","RXL","FTXH","AGNG","LU2129689605.HKD","MEDX","LU1093756325.SGD","VHT","LU0310799852.SGD","ABBV","BK4533","IE0004445239.USD","IE000MB6IJN5.SGD","FHLC","LU1989772923.USD","PJP","IE00B4R5TH58.HKD","LU0198837287.USD","LU1244550221.USD","LU0511384066.AUD","LU0820561909.HKD","GLAM","XLV","LU1934455863.HKD","BK4139","IE0002141913.USD","LU0965509010.AUD","LU2237443622.USD","IE000SO60NU8.SGD","IYH","LU1244550494.USD","LU0456855351.SGD","JDOC","IE00BLSP4452.SGD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664720938","title":"AbbVie Closes $10.9 Billion Acquisition of Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664720938","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664720938?lang=en_us&edition=fundamental","pubTime":"2026-09-03 21:13","pubTimestamp":1788441193,"startTime":"0","endTime":"0","summary":"AbbVie  said Thursday that it has completed its acquisition of Apogee Therapeutics , valuing the clinical-stage biotechnology company at about $10.9 billion, or $135.11 per share.The acquisition is expected to negatively impact adjusted diluted earnings per share by $0.14 in 2026 and by approximately $0.46 in 2027, with accretion beginning in 2032, AbbVie said.Apogee Therapeutics' stock ceased trading on the Nasdaq stock exchange prior to the market open on Sept. 3, according to a statement.AbbVie said it continues to expect Q3 adjusted diluted EPS in the range of $3.84 to $3.88, and full-year adjusted diluted EPS between $13.87 to $14.07.Analysts polled by FactSet expect $3.86 and $14.03, respectively.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","AGNG","LU2237443382.USD","PJP","LU0795875169.SGD","LU0965509101.SGD","LU0432979614.USD","LU2089283258.USD","LU1093756325.SGD","LU0289739343.SGD","IE00BVYPNV92.GBP","JDOC","IE00B19Z3B42.SGD","LU1267930573.SGD","LU1244550494.USD","IXJ","VHT","SBIO","IYH","LU2125909247.SGD","IE00BJJMRZ35.SGD","LU0456855351.SGD","TRUH","ABBV","FHLC","LU0289961442.SGD","LU1061106388.HKD","LU0320765646.SGD","APGE","LU1923622614.USD","LU1023059063.AUD","PPH","LU2237443622.USD","LU0417517546.SGD","LU0310799852.SGD","SG9999011175.SGD","GLAM","LU0738911758.USD","LU0949170772.SGD","LU2129689514.USD","LU0965509010.AUD","RXL","MEDX","LU0057025933.USD","LU0985320562.USD","FTXH","LU0069063385.USD","LU0795875086.SGD","LU1037948897.HKD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664872503","title":"Apogee Therapeutics Shares Face NASDAQ Suspension as Company Moves to Delist After AbbVie Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2664872503","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664872503?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:54","pubTimestamp":1788440071,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics shares face Nasdaq suspension as company moves to delist after AbbVie mergerApogee notified Nasdaq of its merger close, requesting delisting and continued trading halt; shares suspended from trading Sept. 4, 2026.Nasdaq to file SEC Form 25 to delist and deregister the stock under Exchange Act Section 12.Company plans to file SEC Form 15 to terminate registration under Section 12, suspending reporting obligations under Sections 13 and 15.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 03, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL3D254h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU2237443549.SGD","LU1670627923.USD","LU2468319806.SGD","PJP","RXL","ABBV","LU0320765646.SGD","LU0943347566.SGD","IE00BN8TJ469.HKD","LU0882574055.USD","VHT","XLV","LU1934455277.USD","LU2237443895.HKD","LU0128525929.USD","LU1061106388.HKD","LU0985320562.USD","IE00BJJMRZ35.SGD","LU2089284900.SGD","IE000MB6IJN5.SGD","LU2129689514.USD","FTXH","SG9999003800.SGD","LU1023059063.AUD","BK4534","JDOC","GLAM","IE00B3PB1722.GBP","APGE","LU2347655073.USD","IE00B19Z3581.USD","SBIO","FHLC","LU0965508806.USD","IXJ","LU1989771016.USD","IE00B4R5TH58.HKD","MEDX","IYH","TRUH","LU0868494708.USD","LU0965509010.AUD","LU2237443382.USD","LU2347655156.SGD","IE000F7OJYX1.SGD","LU2112291526.USD","LU0820561909.HKD","PPH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874750","title":"Abbvie Completes Acquisition of Apogee Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874750","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874750?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:35","pubTimestamp":1788438900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA5XSP4L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237443465.HKD","PJP","RXL","ABBV","LU2089283258.USD","BK4139","SG9999011175.SGD","LU1496350171.SGD","VHT","IE0002141913.USD","XLV","LU0795875086.SGD","BK4566","LU0912757837.SGD","LU0158827948.USD","SG9999015978.USD","LU0985320562.USD","IE000MB6IJN5.SGD","FTXH","JDOC","IE0004445239.USD","BK4559","GLAM","APGE","LU2087621335.USD","IE00B19Z3581.USD","LU1839511570.USD","SBIO","LU1934455863.HKD","LU0057025933.USD","FHLC","IXJ","LU0511384066.AUD","LU0234570918.USD","LU0820561818.USD","LU1037948541.HKD","LU1291159041.SGD","LU0289739343.SGD","LU2237443978.SGD","MEDX","LU1989772840.SGD","IYH","TRUH","LU0726765562.USD","LU0098860793.USD","IE000F7OJYX1.SGD","LU2112291526.USD","BK4581","PPH","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664787475","title":"Abbvie - Reaffirms 2026 Q3 Adj Diluted EPS Guidance $3.84-$3.88","url":"https://stock-news.laohu8.com/highlight/detail?id=2664787475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664787475?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:35","pubTimestamp":1788438900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA5XSP4L:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BBT3K403.USD","VHT","LU1003077747.HKD","PJP","BK4534","BK4588","TRUH","IE00BJJMRZ35.SGD","LU1244550494.USD","BK4585","LU1929549753.HKD","LU1934455194.USD","LU2023251221.USD","LU0965508806.USD","LU0098860793.USD","BK4581","LU1236620834.HKD","LU1551013342.USD","LU1983299246.USD","IYH","XLV","GLAM","LU0053671581.USD","RXL","LU0114720955.EUR","LU2087621335.USD","IXJ","AGNG","FHLC","LU0456855351.SGD","IE00B3PB1722.GBP","FTXH","LU0234572021.USD","LU0965509101.SGD","LU1718418525.SGD","SG9999015952.SGD","LU0726765562.USD","LU1057294990.SGD","APGE","LU0128525929.USD","JDOC","PPH","LU0029864427.USD","LU1670627923.USD","SBIO","LU0203347892.USD","ABBV","LU0689626769.HKD","MEDX","LU0511384066.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874383","title":"AbbVie to Present at Morgan Stanley Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874383","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874383?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:11","pubTimestamp":1788437512,"startTime":"0","endTime":"0","summary":"AbbVie to present at Morgan Stanley Global Healthcare Conference fireside chatAbbVie will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Sept. 15, 2026.Management is sch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDLbz1b3t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","JDOC","LU2112291526.USD","PJP","XLV","BK4139","RXL","LU0289739343.SGD","LU0158827948.USD","IE000MB6IJN5.SGD","LU0985320562.USD","LU1363072403.SGD","TRUH","IYH","LU0053666078.USD","LU0314104364.USD","LU0795875086.SGD","LU2237443978.SGD","FHLC","ABBV","MEDX","LU1934455863.HKD","IE00B19Z3581.USD","KBWB","LU0511384066.AUD","LU0057025933.USD","IAI","LU1670628061.USD","LU2237443465.HKD","SG9999015978.USD","LU0912757837.SGD","IE0004445239.USD","AGNG","PPH","FTXH","LU1548497426.USD","VHT","BK4559","LU0098860793.USD","LU1037948541.HKD","LU0267386448.USD","IE0002141913.USD","GLAM","IE000F7OJYX1.SGD","SG9999011175.SGD","MS","IXJ","LU1668664300.SGD","LU1291159041.SGD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844898","title":"Estee Lauder’s Sandra Main to Retire as Global Brand President of La Mer, Skin Care Brands by End-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844898","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844898?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:25","pubTimestamp":1788384336,"startTime":"0","endTime":"0","summary":"Estee Lauder’s Sandra Main to retire as global brand president of La Mer, skin care brands by end-2026The Estée Lauder Companies said La Mer and Skin Care Brands President Sandra Main will retire effe","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbq7hN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382058.USD","BK4504","LU2404859667.USD","LU2264538146.SGD","LU1988902786.USD","BK4558","BK4183","EL","LU0690374615.EUR","GLAM","BK4229","LU2552382215.SGD","BK4195","LU2552382132.HKD","BK4588","LU1064131342.USD","LU0690374961.EUR","AGM","BK4585","BK4533","LU2404859741.USD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664841722","title":"Align Technology Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841722","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841722?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:14","pubTimestamp":1788383640,"startTime":"0","endTime":"0","summary":"DJ Align Technology Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Align Technology Inc.  advanced 2.70% to $159.15 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.46% to 7,666.60 and the Dow Jones Industrial Average  rising 0.56% to 53,061.95.Align Technology Inc. closed 20.60% short of its 52-week high of $200.44, which the company achieved on April 21st.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Zimmer Biomet Holdings Inc.  rose 0.10% to $99.50 and Dentsply Sirona Inc.  rose 4.93% to $11.29.Trading volume  remained 269,884 below its 50-day average volume of 956,938.Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708994859.HKD","LU1974910355.USD","BK4082","LU0128525929.USD","IE0002270589.USD","LU0130517989.USD","LU1267930573.SGD","LU0889566641.SGD","BK4585","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0648001328.SGD","LU1201861249.SGD","BK4588","LU0006061336.USD","ZBH","LU0792757196.USD","LU0310800379.SGD","LU1267930813.SGD","BK4566","LU2023250504.SGD","GLAM","LU0211327993.USD","XRAY","BK4198","IE00B19Z3581.USD","LU1917777945.USD","LU0310799852.SGD","ALGN","LU0477156953.USD","LU0980610538.SGD","LU2106854487.HKD","BK4534","LU1267930490.SGD","BK4504","LU0211328371.USD","LU0029864427.USD","LU0130102774.USD","LU2023250843.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664180841","title":"STAAR Surgical Appoints Ben Park as Chief Technology Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664180841","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664180841?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:57","pubTimestamp":1788382630,"startTime":"0","endTime":"0","summary":"STAAR Surgical (STAA) appointed Ben Park as chief technology officer.Park most recently served as head of emerging technology at Align Technology (ALGN), STAAR said Wednesday in a statement.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2106854487.HKD","BK4588","BK4198","ALGN","BK4504","GLAM","STAA","BK4585","LU1974910355.USD","BK4534","LU1917777945.USD","LU2023250843.SGD","LU2023250504.SGD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664841904","title":"Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664841904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664841904?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:54","pubTimestamp":1788382440,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Wednesday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  advanced 1.15% to $101.15 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.46% to 7,666.60 and the Dow Jones Industrial Average  rising 0.56% to 53,061.95.The stock's rise snapped a three-day losing streak.Estee Lauder Cos. Cl A closed 16.84% below its 52-week high of $121.64, which the company reached on February 3rd.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 1.48% to $275.21, Procter & Gamble Co.  rose 0.98% to $147.64, and Coty Inc. Cl A  rose 2.11% to $2.90.Trading volume  remained 131,050 below its 50-day average volume of 3.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled September ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3PB1722.GBP","PG","TRUO","LU1674673691.USD","LU0098860793.USD","GLAM","LU0096364046.USD","IE00B2B36J28.USD","JNJ","PJP","LU2471134952.CNY","IE000SO60NU8.SGD","GDOC","XLV","LU0943347566.SGD","IXJ","LU1868837300.USD","EL","BK4567","LU0061475181.USD","LU1145028129.USD","IHE","LU1914381329.SGD","FSTA","JDOC","RXL","XLP","LU2404859741.USD","IE0000B7K699.USD","TRUH","IYH","LU2417539215.USD","UGE","VHT","IE0001KFT4U8.USD","COTY","FTXH","LU0912757837.SGD","LU1064131342.USD","LU0787776722.HKD","IE00BLSP4239.USD","LU1066053197.SGD","MEDX","LU1988902786.USD","FHLC","LU0426412945.USD","LU2129689605.HKD","GB00BDT5M118.USD","IE00B19Z3B42.SGD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664192248","title":"Allergan Aesthetics Unveils Layered Beauty Report on Global Shift Toward Personalized Aesthetic Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2664192248","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664192248?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:04","pubTimestamp":1788350648,"startTime":"0","endTime":"0","summary":"Allergan Aesthetics unveils Layered Beauty report on global shift toward personalized aesthetic careAllergan Aesthetics, an AbbVie unit, released a global “Layered Beauty” report on shifting consumer ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL3WxBkY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203347892.USD","IE00B3PB1722.GBP","SG9999001440.SGD","ABBV","LU1037948541.HKD","LU0861579265.USD","LU0211327993.USD","FHLC","LU0432979614.USD","IE00BDGV0183.EUR","LU1551013342.USD","SG9999011175.SGD","IYH","BK4533","IE00BSNM7G36.USD","LU0203345920.USD","LU0289961442.SGD","LU2468319806.SGD","LU0868494708.USD","LU2237443622.USD","TRUH","GLAM","LU0289739699.SGD","LU2433249047.HKD","IXJ","MEDX","AGNG","LU0708994859.HKD","LU1244550221.USD","PPH","LU1989772840.SGD","IE00B42XCP33.USD","LU0943347566.SGD","BK4588","VHT","LU0882574055.USD","LU1718418525.SGD","IE0009355771.USD","LU0256863811.USD","LU1989772923.USD","PJP","JDOC","XLV","FTXH","BK4534","LU0098860793.USD","RXL","LU0158827948.USD","BK4566","LU0689472784.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}